Saulius Butenas Selected Research

Factor IXa (Coagulation Factor IXa)

8/2022	Active FXI Can Independently Predict Ischemic Stroke in Anticoagulated Atrial Fibrillation Patients: A Cohort Study.
1/2018	Analysis of factor XIa, factor IXa and tissue factor activity in burn patients.
10/2016	Activated factor IX, factor XI and tissue factor identify patients with permanent atrial fibrillation treated with warfarin who are at risk of ischemic stroke.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Saulius Butenas Research Topics

Disease

10	Wounds and Injuries (Trauma) 03/2021 - 03/2006
7	Hemophilia A (Haemophilia) 08/2018 - 02/2002
6	Acute Coronary Syndrome 01/2022 - 08/2003
6	Hemorrhage 08/2018 - 10/2007
5	Thrombosis (Thrombus) 08/2022 - 08/2003
5	Cardiovascular Diseases (Cardiovascular Disease) 03/2019 - 10/2007
4	Ischemic Stroke 01/2022 - 02/2012
4	Myocardial Infarction 01/2019 - 01/2003
4	Atrial Fibrillation 01/2018 - 09/2010
3	Venous Thromboembolism 01/2022 - 06/2020
3	Inflammation (Inflammations) 01/2019 - 01/2008
3	Hemophilia B (Haemophilia B) 12/2012 - 02/2002
3	Stable Angina 04/2012 - 01/2008
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 01/2008
2	Lung Neoplasms (Lung Cancer) 03/2019 - 12/2018
2	Neoplasms (Cancer) 03/2019 - 12/2018
2	Thromboembolism 03/2019 - 12/2018
2	Vascular System Injuries 01/2012 - 12/2009
2	Stroke (Strokes) 11/2011 - 01/2003
1	Shock 01/2021
1	Burns 01/2018
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 07/2017
1	Leukemia 09/2013
1	Aortic Valve Stenosis (Aortic Stenosis) 09/2011
1	Chronic Obstructive Pulmonary Disease (COPD) 03/2011
1	Systolic Heart Failure 09/2010
1	Cardiomyopathies (Cardiomyopathy) 09/2010
1	Heart Failure 09/2010
1	Critical Illness (Critically Ill) 08/2009
1	Vascular Diseases (Vascular Disease) 01/2008
1	Pain (Aches) 01/2008
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2003
1	Pulmonary Embolism 01/2003

Drug/Important Bio-Agent (IBA)

22	Thrombin FDA Link 03/2021 - 02/2002
18	Thromboplastin (Tissue Factor)IBA 08/2022 - 08/2003
9	Factor XIa (Coagulation Factor XIa)IBA 01/2022 - 01/2008
4	FibrinIBA 01/2020 - 04/2008
4	Proteins (Proteins, Gene)FDA Link 01/2019 - 03/2006
4	ProteomeIBA 12/2012 - 03/2006
4	Factor VIIa (Activated Factor VII)IBA 01/2012 - 02/2002
3	Factor IXa (Coagulation Factor IXa)IBA 08/2022 - 10/2016
3	AntibodiesIBA 01/2019 - 03/2009
3	AnticoagulantsIBA 04/2012 - 09/2010
2	Factor XI (Plasma Thromboplastin Antecedent)IBA 01/2022 - 10/2016
2	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2020 - 10/2017
2	Fibrinogen (Factor I)FDA Link 12/2018 - 03/2011
2	Factor VIII (Coagulation Factor VIII)IBA 08/2018 - 03/2009
2	von Willebrand FactorIBA 07/2017 - 10/2016
2	Citric Acid (Citrate)FDA LinkGeneric 01/2017 - 01/2008
2	Interleukin-6 (Interleukin 6)IBA 10/2016 - 03/2011
2	Blood Coagulation Factors (Coagulation Factor)IBA 10/2016 - 09/2010
2	Warfarin (Coumadin)FDA LinkGeneric 10/2016 - 01/2011
2	lipoprotein-associated coagulation inhibitor (TFPI)IBA 12/2012 - 04/2012
2	prothrombin fragment 1.2IBA 09/2011 - 03/2011
2	Hemostatics (Antihemorrhagics)IBA 08/2009 - 01/2008
1	RivaroxabanIBA 06/2020
1	CotinineIBA 03/2019
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2019
1	Histones (Histone)IBA 01/2019
1	Peroxidase (Myeloperoxidase)IBA 01/2019
1	Leukocyte Elastase (Neutrophil Elastase)IBA 01/2019
1	Cell-Free Nucleic AcidsIBA 01/2019
1	fibrin fragment D (D-dimer)IBA 12/2018
1	Troponin IIBA 01/2018
1	Metalloproteases (Metalloproteinases)IBA 07/2017
1	ThrombospondinsIBA 07/2017
1	Monoclonal AntibodiesIBA 10/2016
1	LipopolysaccharidesIBA 09/2013
1	Thomsen-Friedenreich antigenIBA 09/2013
1	ARC19499IBA 12/2012
1	Free RadicalsIBA 04/2012
1	EnzymesIBA 01/2012
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2011
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 03/2011
1	Matrix Metalloproteinases (MMPs)IBA 03/2011
1	C-Reactive ProteinIBA 03/2011
1	Prothrombin (Factor II)IBA 09/2010
1	CoagulantsIBA 01/2008
1	Biological ProductsIBA 10/2007
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 08/2003
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2003
1	recombinant FVIIa (rFVIIa)FDA Link 01/2003
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 02/2002

Therapy/Procedure

4	Therapeutics 03/2019 - 01/2008
1	Drug Therapy (Chemotherapy) 12/2018
1	Percutaneous Coronary Intervention 08/2003